CD133+ Autologous Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD133+ Autologous Cells, covering 2006-11-17 to 2006-11-17. Get the full timeline:
Most recent: Clinical Trial Update: CD133+ Autologous Cells After Myocardial Infarction [Phase 1, Phase 2]